Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe COPD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT07252908
What this trial is testing

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 195
Testing effectiveness (Phase 2)Study completedNCT01049360
What this trial is testing

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 128
Not applicableStudy completedNCT02187926
What this trial is testing

Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 2,577
Large-scale testing (Phase 3)Study completedNCT01782326
What this trial is testing

QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 3,362
Large-scale testing (Phase 3)Study completedNCT01854658
What this trial is testing

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Pearl Therapeutics, Inc. 1,615
Post-approval studies (Phase 4)Study completedNCT02211118
What this trial is testing

Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD

Who this might be right for
COPDSedationDexmedetomidine
Dayton VA Medical Center 30
Not applicableLooking for participantsNCT07213128
What this trial is testing

Effect of IMT in Patients After Acute Exacerbations of COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseasesCOPDSymptom Exacerbation
KU Leuven 358
Not applicableStudy completedNCT00380796
What this trial is testing

A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Who this might be right for
COPDPulmonary Disease, Chronic Obstructive
Centocor, Inc. 88
Not applicableUnknownNCT06476769
What this trial is testing

Combined Effects of Blow Bottle Device and Postural Drainage in Moderate to Severe Elderly COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Riphah International University 40
Not applicableNot Yet RecruitingNCT07361653
What this trial is testing

The REVIVE Pivotal Study

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)COPD ExacerbationsCOPD Patients+4 more
Ryme Medical, Inc. 300
Not applicableStudy completedNCT05750810
What this trial is testing

Exacerbations and Their Outcomes International (EXACOS International)

Who this might be right for
COPDExacerbation Copd
Joon Young Choi 3,477
Testing effectiveness (Phase 2)Looking for participantsNCT07668518
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Kither Biotech Srl 36
Not applicableWithdrawnNCT06983340
What this trial is testing

EXACOS EG Population

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca
Post-approval studies (Phase 4)Study completedNCT02153489
What this trial is testing

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 30
Large-scale testing (Phase 3)Study completedNCT03836677
What this trial is testing

Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 23
Post-approval studies (Phase 4)Study completedNCT03842904
What this trial is testing

A Study Comparing the Effects of Trimbow to Fostair in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Medicines Evaluation Unit Ltd 23
Large-scale testing (Phase 3)Study completedNCT00274014
What this trial is testing

Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 1,000
Not applicableUnknownNCT02755363
What this trial is testing

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD
Medical University of Warsaw 20
Large-scale testing (Phase 3)Study completedNCT01353235
What this trial is testing

Oral Prednisolone in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD Exacerbation
Fekri Abroug 317
Testing effectiveness (Phase 2)Study completedNCT01227278
What this trial is testing

Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
MedImmune LLC 421
Next Page